How would results surprise? I would think the expectation from most would be that results of 'single-dose' trials would be highly successful and mostly factored in already.
Mak thats not my view. These single dose trials will " characterise" the final Oxy Patch Design. Its a very different patch from what I understand was trialled earlier and is greatly improved. So this trial determines much about the profile of the Oxy patch, its potential uses, future markets and opportunities. I expect good news based on previous results but what form that news will take is an unknown - so there could be much to surprise the market with these results.
esra ogru background, page-70
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.226K | 1.116M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 92468918 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 76402411 | 25 |
View Market Depth
| Last trade - 12.50pm 06/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |